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We have recently reported that the bioactive lipid sphingosine-1-phosphate (S1P), usually signaling proliferation and
anti-apoptosis induces neuronal death when generated by sphingosine-kinase2 and when accumulation due to S1P-lyase
deﬁciency occurs. In the present study, we identify the signaling cascade involved in the neurotoxic effect of sphingoid-base
phosphates. We demonstrate that the calcium-dependent cysteine protease calpain mediates neurotoxicity by induction of the
endoplasmic reticulum stress-speciﬁc caspase cascade and activation of cyclin-dependent kinase5 (CDK5). The latter is
involved in an abortive reactivation of the cell cycle and also enhances tau phosphorylation. Neuroanatomical studies in the
cerebellum document for the ﬁrst time that indeed neurons with abundant S1P-lyase expression are those, which degenerate
ﬁrst in S1P-lyase-deﬁcient mice. We therefore propose that an impaired metabolism of glycosphingolipids, which are prevalent
in the central nervous system, might be linked via S1P, their common catabolic intermediate, to neuronal death.
Cell Death and Differentiation (2011) 18, 1356–1365; doi:10.1038/cdd.2011.7; published online 18 February 2011
Gangliosides, a class of sialic acid containing complex
glycosphingolipids are characteristic components of neuronal
cells. Neuronal ganglioside proﬁles vary in different regions of
the brain and characteristically change during ontogenesis.
1
The possible physiological role of these complex molecules
for neuronal function and neurodegeneration has been
extensively studied.
2
Reports on elevated expression and activity of enzymes
involved in sphingolipid degradation in brain samples of
patients suffering from Alzheimer’s disease also suggest that
lesscomplexmetabolicintermediatesoftheseabundantbrain
lipids might contribute to neurodegeneration.
3 Among these,
ceramide, the central metabolic intermediate and sphingo-
sine-1-phosphate (S1P), the common degradation product of
all glycosphingolipids (Figure 1) appear to be of speciﬁc
interest given their diverse biological functions.
4 In most cell
types S1P and its metabolic precursor ceramide exert
antagonistic effects on cell survival. Owing to its tissue
protective properties S1P turned out to be primarily a survival
signal, whereas ceramide was shown to mediate cellular
stress response.
4
Note that phosphorylation of sphingosine is catalyzed by
sphingosine-kinase (SK) of which two distinct isoforms, SK1
and SK2, have been cloned and characterized.
5,6 Degrada-
tion of S1P occurs either via reversible dephosphorylation to
sphingosine or via irreversible cleavage by the endoplasmic
reticulum (ER) resident S1P-lyase
1 (Figure 1), suggesting a
tight regulation and maintenance of low cellular levels of this
bioactive molecule.
S1P exerts its functions either as a ligand for a family of
ﬁve speciﬁc G-protein coupled receptors (S1P1–5)o ra sa n
intracellular second messenger.
7 In contrast to the well-
characterized receptor-mediated effects of S1P, much less is
known about its intracellular actions. One of the intracellular
effects of S1P is its involvement in calcium homeostasis.
8,9
The complex biological effects of S1P are cell type and
differentiation speciﬁc. Thus, S1P induces proliferation in
neuronal progenitor cells
10 but apoptosis in hippocampal
neurons.
11 We have recently shown that accumulation of S1P
in S1P-lyase-deﬁcient neurons induces apoptosis as well.
12
This neurotoxic effect was independent of S1P receptors but
involved dephosphorylation to sphingosine and rephosphory-
lation catalyzed by SK2.
12 A similar effect was observed with
the synthetic sphingosine analog cis-4-methylsphingosine
(cimes).
13 Cimes is taken up by the cells and mainly phos-
phorylated by SK2 to form cis-4-methylsphingosine-phos-
phate (cimesP).
12 This semi-synthetic S1P analog turned out
to be metabolically stable, thus accumulating inside most cell
types investigated so far.
12–15 Like S1P, cimesP stimulated
proliferation of quiescent Swiss 3T3 ﬁbroblasts.
15
S1P generated in the ER membrane has been shown to
activate release of calcium from inositol 1,4,5-trisphosphate-
sensitive calcium pools.
8 The neurotoxic effect of S1P and
cimesP generated by SK2 in ER membranes
12 might,
therefore, be associated with the disruption of calcium
homeostasis.
This possibility is supported by experimental evidence
indicating that the deregulation of the cysteine protease
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www.nature.com/cddcalpain is a key cytotoxic event in a variety of neurodegen-
erative processes.
16 Calpain activity triggered by elevated
intracellular calcium levels is often associated with activation
of cyclin-dependent kinase5 (CDK5).
16 Interestingly, several
brain pathologies with neuronal CDK5 dysregulation also
exhibit re-expression of different cell cycle markers in
terminally differentiated neurons.
17 Indeed, cell cycle reacti-
vation is considered an important feature of neurological
disorders.
18
In this study, we investigated the molecular mechanism of
neuronal apoptosis elicited by S1P accumulation. Parallel
experiments were conducted using S1P in S1P-lyase-
deﬁcient neurons or the semi-synthetic cimesP in wild-type
neurons. Our results suggest that neuronal death induced by
sphingoid-base phosphates is independent of mitochondria
butinvolves calpain activation. Thisprotease triggeredthe ER
stress-speciﬁc caspase cascade and also CDK5-mediated
cell cycle re-entry. Calpain-dependent CDK5 activation could
be correlated in addition with hyperphosphorylation of tau,
that forms neuroﬁbrillary tangles in AD and several other
neurological disorders known as tauopathies.
19 In this study,
we also provide evidence of the pathophysiological impact of
sphingoid-base phosphate neurotoxicity. The apoptotic path-
way described in this study may, therefore, be of particular
interestforthe development ofnew strategiesinthe treatment
of neurodegenerative disorders that are triggered by sphin-
goid-base phosphates generated by SK2.
Results
Cimes fails to induce apoptosis in sphingosine-kinase2-
deﬁcient neurons. In a previous study, we have shown that
cimesP is mainly generated by SK2.
12 We have also shown
that in S1P-lyase-deﬁcient neurons S1P induces apoptosis
only when generated by SK2.
12 We now compared the
neurotoxicity of cimes in granule cells prepared from wild-
type, SK1- and SK2-deﬁcient mice. As depicted in Figure 2
cimes reduced viability of wild-type neurons as well as of
SK1-deﬁcient cells, whereas it did not affect viability of SK2-
deﬁcient neurons (Figure 2a). Accordingly, effector-caspase
activation was measured only in wild-type and SK1-deﬁcient
neurons (Figure 2b). Similarly, DNA fragmentation occurred
only in these two cell types (Figure 2c) whereas SK2-
deﬁcient neurons were unaffected (Figure 2). Therefore, the
reader should keep in mind that throughout this study cells
were incubated with cimes but the biologically active
compound was, in fact, SK2-generated phosphate (cimesP).
Cimes induces intracellular calcium signaling without
affecting mitochondrial function. Extracellular application
of cimes or S1P leads to an increase in the intracellular
calcium concentration,
15 most likely due to release of calcium
from the ER.
8 Prolonged incubation of cerebellar neurons
with cimes, which leads to the intracellular accumulation of
the metabolically stable cimesP, induced long-lasting and
persistent increases in the resting intracellular calcium ([Ca]i)
which amounted up to 900nM after 16h of incubation
(Figure 3a). As expected, incubation of neurons (up to
24h) with the short-lived S1P had no effect on the resting
[Ca]i (Figure 3a). Yet, brief applications of S1P induced a
transient increase of [Ca]i (Figure 3b), a ﬁnding that is
consistent with previous reports on different cell types.
9,15 To
assure that neurons were capable to produce calcium signals
cells were challenged with high extracellular potassium. As
shown in Figure 3b, 495% of the cells responded with robust
transient increases in [Ca]i upon KCl-induced depolarization.
Disturbance of calcium homeostasis often affects mito-
chondrial functions.
20 We therefore investigated whether
mitochondria are involved in cimes-induced neuronal cell
death by studying cytochrome c release into cytosol. How-
ever, cytochrome c could not be detected in the cytosolic
fraction of cells treated with cimes (10mM) indicating integrity
of mitochondria (Figure 3c). To verify our ﬁndings we used
neurons from S1P-lyase-deﬁcient mice incubated with S1P
(10mM) and compared them to wild-type neurons treated
alike. As illustrated in Figure 3d, no cytochrome c could
be detected in the cytosolic fraction of S1P-lyase-deﬁcient
mice in the presence of S1P.
Furthermore, mitochondrial integrity was analyzed in the
absence or presence of cimes using the ﬂuorescent cationic
dye JC-1. These measurements revealed that cimes does
not reduce the number of intact mitochondria in terminally
differentiated cerebellar neurons (Figure 3e). As positive
control neurons were incubated in the presence of carbonyl-
cyanide m-chlorophenyl hydrazone (CCCP), which abolishes
mitochondrial membrane potential (Figure 3e).
Mitochondria independent apoptosis is promoted by
caspase-9 and caspase-12. As shown in Figure 2b
caspase activity is considerably increased in cells
incubated with cimes. We therefore examined which of the
initiator-caspases was responsible for activation of effector-
caspase-3. As depicted in Figure 4a caspase-8 was not
activated in the presence of the sphingoid-base phosphate.
Instead of that caspase-9 was activated (Figure 4b), which is
usually linked to the mitochondrial death pathway that
we just excluded (see above). To conﬁrm this unexpected
result we used Z-LEHD-FMK, a speciﬁc caspase-9 inhibitor,
which almost completely prevented cimes-induced effector-
caspase-3 activation (Figure 4c). However, neuronal viability
Ceramide
Sphingomyelin
Sphingosine
Serine +
PalmitoylCoA
Hexadecenal +
Phosphoethanolamine
SMase SMS
CDase SK
SPL
SPT
CS SPP
S1P Glycosphingolipids
(Gangliosides)
Figure 1 Scheme of sphingolipid metabolism. Ceramide is formed either
de novo starting from serine and palmitoylCoA or by hydrolysis of sphingomyelin
or glycosphingolipids including gangliosides. In addition, its degradation product
sphingosine can be recycled back to ceramide by ceramide synthase (CS). It is
degraded by ceramidases (CDases) to yield sphingosine, which in turn is
phosphorylated by sphingosine-kinases (SK) to generate sphingosine-1-phosphate
(S1P). The latter is either cleaved by S1P-lyase (SPL) into hexadecenal and
phosphoethanolamine or dephosphorylated back to sphingosine by S1P-
phosphatases (SPP). SMS, sphingomyelin synthase; SMase, sphingomyelinase;
SPT, serine palmitoyltransferase.
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Cell Death and Differentiation(Figure 4e) and DNA integrity (Figure 4d) were only partially
improved by this inhibitor. As caspase-9 was activated
independently of cytochrome c release, we considered an
alternative activation pathway, namely, the ER
stress-speciﬁc apoptotic pathway involving particularly
caspase-12.
21,22 Consistent with this pathway, we found an
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Cell Death and Differentiationactivation of caspase-12 in the presence of cimesP
(Figure 4f) that, in turn, activates caspase-9 in a cyto-
chrome c independent manner.
Calpain mediates cimes-induced neurotoxicity. As
shown in Figure 4 reduced cell viability and apoptotic DNA
cleavage persisted even after almost complete abrogation of
caspase activity. Based on the fact that sphingoid-base
phosphates induce calcium release from the ER
8 and calpain
was shown to induce caspase-9 independently of cyto-
chrome c release,
23 we explored a possible involvement of
this calcium-dependent regulatory protease in cimes-induced
neurotoxicity. On the one hand, western blot analysis
revealed a strong upregulation of calpain expression in
neurons incubated with cimes (Figure 5a). On the other
hand, MDL28170, an effective pharmacological inhibitor
shown to speciﬁcally suppress calpain activity,
24 completely
rescued neurons from cimes-induced toxicity (Figure 5b).
Accordingly, pre-incubation of cells with MDL28170 (10mM)
largely prevented caspase activation and DNA degradation
(Figures 5c and d). Interestingly, inhibition of calpain also
prevented morphological changes induced by cimes
(Figure 5e). As it becomes clear from Figure 5e, neurons
treated with cimes (24h, 10mM) showed the typical changes
in morphology, speciﬁcally cell-aggregates connected by
radially running neurites, whereas MDL-treated neurons
retained the morphology of control cells.
Reactivation of cell cycle depends on calpain and CDK5/
p25. We have shown previously that cimes as well as S1P-
induced neuronal apoptosis involves an inappropriate cell
cycle reactivation.
12,13 The fully protective effect of MDL
encouraged us to investigate the role of calpain for cell
cycle reactivation in these post-mitotic neurons. First, we
examined whether depletion of cytosolic calcium affects
cimes-induced expression of cyclin D1. As depicted in
Figure 6a, the cell permeable calcium-chelator Bapta-AM
completely abrogated cyclin D1 expression induced by
cimes. We observed the same result after incubation of the
cells with the calpain inhibitor MDL (Figure 6b), once more
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Cell Death and Differentiationsuggesting the involvement of calcium-dependent factors
in the observed neurotoxic effects of sphingoid-base phos-
phates. We therefore aimed to identify downstream targets
of calpain, which could promote cell cycle re-entry. As shown
in Figures 6c and e, MDL substantially abrogates cimes-
induced upregulation of CDK5 and p25, suggesting their
involvement in signaling downstream of calpain. Similar results
were obtained with S1P in S1P-lyase-deﬁcient neurons
(Figure 6d). Furthermore, MDL completely abolished cimes-
induced phosphorylation and thus inactivation of the inhibitory
cell cycle regulator Rb (retinoblastoma protein) (Figure 6f).
These results indicate that reactivation of neuronal cell cycle
involves cytosolic calcium and a calpain-dependent formation
of p25 accompanied by an upregulation of CDK5 and
phosphorylation of Rb.
Calpain mediates cimes-induced tau hyperphosphorylation.
Hyperphosphorylation of the microtubule-associated protein tau
is a characteristic feature of neurodegenerative disorders
(tauopathies) including Alzheimer’s disease.
25 We therefore
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Cell Death and Differentiationinvestigated whether sphingoid-base phosphates promote
excessive phosphorylation of tau. Indeed, incubation of wild-
type and S1P-lyase-deﬁcient neurons with cimes and S1P,
respectively, results in an enhanced tau phosphorylation at the
PHF-1 site (S396 and S404) (Figure 7a). Further studies
with cimes revealed additional phosphorylation of tau at the
12E8 site (S262 and S214) (Figure 7b). PHF-1 recognizes
phosphorylated motifs in the ﬂanking region of the internal
repeat domain while 12E8 binds to phosphorylated serine
residues of the KXGS motifs within the repeat domain. In both
cases the calpain inhibitor MDL reversed cimes-induced
hyperphosphorylation of tau, whereas MDL alone did not
affect tau phosphorylation.
Pathophysiological impact of S1P. To investigate the
physiological relevance of accumulating sphingoid-base
phosphates, we compared sagittal sections through the
cerebellar vermal region of S1P-lyase-deﬁcient and wild-type
mice. As shown in Figure 8, S1P-lyase immunoreactivity
is mainly and regularly present in Purkinje cells as well as
in (Bergmann) glial cell processes and some scattered
interneurons (Figures 8a and b). Note that in corresponding
regions from cerebella of S1P-lyase-deﬁcient mice no
immunoreactivity was detectable (Figures 8c and d). Ana-
lysis of the cerebellar cortex of wild-type (Figure 8e) and
S1P-lyase-deﬁcient mice (Figure 8f) reveals the presence of
scattered small groups of degenerating Purkinje cells only in
S1P-lyase-deﬁcient mice.
Discussion
In a recent study, we have shown that in terminally
differentiated neurons cimes is mainly phosphorylated by
SK2 (90%) and only a poor substrate for SK1.
12 We now
demonstrate that SK2 activity is indispensable for the
apoptotic effect of cimes. Thus, our results clearly show that
cimes induces apoptosis in wild-type and SK1-deﬁcient
neurons whereas it fails to induce apoptosis in SK2-deﬁcient
neurons. It is well known that the two isoenzymes catalyzing
sphingosine phosphorylation have opposite effects on cellular
growth and apoptosis. While SK1 generates S1P, which
promotes cell growth and rescues cells from ceramide-
inducedapoptosis,overexpressionofSK2suppressesgrowth
and enhances cell death.
7 Interestingly, structural analogs of
sphingosine, including FTY720,
26 FTY720 analogs
27 and
cimes
12 are mainly phosphorylated by the less substrate-
speciﬁc SK2.
6 It was shown that some of them induced
apoptosis.
12,27
Despite some contradictory ﬁndings on localization of SK
isoenzymes, it is generally accepted that SK1 is predomi-
nantly cytosolic and translocated to the plasma membrane
upon activation
7,28 whereas SK2 is associated with internal
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Cell Death and Differentiationmembranes, predominantly the ER.
20,27 Interestingly, SK1
also promoted apoptosis when targeted to the ER
20 indicating
that ER localization rather than the enzyme by itself is
essential for the apoptotic effect. Using ﬂuorescent deriva-
tives, it has been shown that sphingoid-base phosphate
analogs generated by SK2 accumulate mainly in ER
membranes.
27 In light of these results and in agreement with
an ER localization of SK2, it appears quite likely that cimes
phosphorylated by SK2 also accumulates in ER membranes.
Moreover,we couldshow inthis study that cimesdownstream
signaling is promoted by ER-speciﬁc proteases, including
calpain and caspase-12. In addition, we could exclude
involvement of mitochondria in cimes-induced neuronal
apoptosis. This was an unexpected ﬁnding given the clear
activation of caspase-9, which has been shown to depend on
cytochrome c release.
29 Also, mitochondria permeabilization
was proposed as part of the sphingoid-base phosphate-
induced apoptotic pathway in immune cells.
27 Cimes failed,
however, to induce cytochrome c release and caspase-8
activation indicating that the sphingoid-base phosphate
pro-apoptotic pathway in neurons is different.
The observation that caspase-9 was activated inde-
pendently of cytochrome c release, prompted us to look for
ER-dependent factors that might be responsible for sphin-
goid-base phosphate-induced activation of procaspase-9.
In agreement with previous ﬁndings,
22 our results indicate
that cimes activates caspase-12, which then speci-
ﬁcally cleaves procaspase-9 in a mitochondria-independent
manner. Cleavage and hence activation of caspase-12 has
been suggested to be catalyzed by calpain.
23 This cytosolic
protease is activated by increased cytosolic calcium levels,
which induce its translocation from the cytosol to ER
membranes. As cimes promoted a persistent elevation of
intracellular calcium concentration, activation of calpain
appeared quite likely. Calpain activation has been described
in several neuronal pathologies, many of them including
CDK5 dysregulation caused by calpain catalyzed cleavage of
CDK5 regulatory subunit p35.
30 The resulting p25 subunit
lacks the membrane anchor binding site generating a
hyperactive and mislocalized CDK5/p25 complex.
30 Note,
that CDK5 is essential for normal brain development and
function, but uncontrolled activity may lead to numerous
neurodegenerative diseases.
31 Neurotoxicity caused by the
CDK5/p25complexhasbeensuggestedtobeassociatedwith
hyperphosphorylation of tau
32 and/or reactivation of the cell
cycle.
33 Notably, cimes stimulates tau phosphorylation and
induces cell cycle re-entry (Figure 9). Moreover, both effects
are calpain and CDK5/p25 dependent. Hyperphosphory-
lation of tau caused by cimes strongly suggests that neuro-
toxicity of sphingoid-base phosphates might be related to an
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Figure 7 Calpain mediates cimes-induced tau hyperphosphorylation. (a) Cerebellar neurons from wild-type (þ/þ) and S1P-lyase-deﬁcient ( / ) mice were incubated
for 24h with vehicle (ctrl, control), cimes or S1P (10mM each). (b) Alternatively, wild-type cerebellar neurons were pre-incubated for 1h with MDL 28170 where indicated.
Thenvehicle(ctrl,control)orcimes(10mM)wereaddedfor24hasindicated.Shownarerepresentativewesternblotsobtainedwiththespeciﬁcphospho-tauantibodiesPHF-1
(Ser-396/404) and 12E8 (pS262/356) recognizing pathological phosphoepitopes of tau. The total amount of tau was visualized using the pan-tau antibody K9JA. Quantitative
data (mean values±S.D., n¼4) were evaluated by densitometry and are given relative to the respective untreated controls (ctrl). *Po0.05
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Cell Death and Differentiationabnormal tau aggregation. Interestingly, tau hyperphosphor-
ylation was also reported in fetal tissue and in mitotic cells
indicating that mitotic signals might be able to cause
hyperphosphorylation of tau and hence apoptotic death in
differentiated neurons.
34 The mitogenic potential of cimes
15
argues in favor of this hypothesis.
Collectively,ourdataindicatethatsphingoid-basephosphates
cause neuronal death by a calpain-mediated mechanism
involving CDK5/p25 and the ER stress-speciﬁc caspase
cascade (Figure 9).
Intriguingly, S1P-dependent neurotoxicity described in the
present study shows similarity to that of the amyloid b-peptide
in Alzheimer’s disease. Thus, amyloid b-peptide neurotoxicity
also involves procaspase-12 activation by disruption of ER
calcium homeostasis but not by membrane- or mitochondria-
targeted apoptotic signals.
21 Furthermore, amyloid b-peptide
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Figure 8 Correlation between S1P-lyase immunoreactivity and neuronal degeneration. Cerebella of wild-type (a and b) and S1P-lyase-deﬁcient (c and d) mice
were stained with an antibody against S1P-lyase. Immunoreactivity for S1P-lyase is mainly present in Purkinje cell somata (arrows in a and b) and proximal dendrites
(arrowheadinb)aswellasintheperivascularandsuperﬁcialgliallimitingmembrane(arrowheadina).Sectionsofcorrespondingregionsfromknockoutmicecerebella(cand
d) are devoid of S1P-lyase immunoreactivity. Sagittal sections through the cerebellar vermal region of adult wild-type (þ/þ, e) and S1P-lyase-deﬁcient ( / , f) mice were
stained with toluidine blue and pyronin (g). Arrows in Figure 8f indicate scattered groups of degenerating Purkinje neurons in the cerebellar cortex. The insert in Figure 8f
shows two degenerating neurons at higher magniﬁcation, featuring darkened cytoplasm, irregular shrunken contours and in one case nuclear pyknosis. Bars correspond to
300mm( a and c), 30mm( b and d), and 50mm( e and f)
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Figure 9 Proposed signaling cascade of sphingoid-base phosphate-induced neurotoxicity. Calpain is the central signaling molecule and mediates sphingoid-base
phosphate-induced neuronal apoptosis by activation of ER stress-speciﬁc caspase cascade and initiation of cell cycle reactivation. In addition, calpain/CDK5-dependent tau
hyperphosphorylationisinduced.ThemetabolicfateofexogenouscimesandS1Pinwild-typeandS1P-lyase-deﬁcientmice,respectively, wasdescribedpreviously.
12 CDK5,
cyclin-dependent kinase5; cimes, cis-4-methylsphingosine; cimesP, cis-4-methylsphingosine-phosphate; ER, endoplasmic reticulum; Rb, retinoblastoma protein; SK2;
sphingosine-kinase2; Sph, sphingosine; SPP, sphingosine-phosphate phosphatase
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Cell Death and Differentiationinduces an aberrant reactivation of cell cycle events and
activation of CDK5.
35 Notably, calpain emerged as a central
player in the pathogenesis of neurological diseases
16 thus
suggesting a pathophysiological relevance of our results.
Accordingly, an impaired metabolism of glycosphingolipids,
which are highly abundant in the central nervous system,
might be linked via S1P, their common catabolic intermediate,
to neuronal death. Neuroanatomical studies document for the
ﬁrst time that indeed neurons with abundant S1P-lyase
expression are those, which degenerate ﬁrst in S1P-lyase-
deﬁcient mice. This ﬁnding suggests that S1P might be the
missing link connecting impaired lipid metabolism and
neurological disorders.
Materials and Methods
Cell culture. Granule cells from cerebella of 6 days old wild-type, S1P-lyase
(sgpl1)  / , sphingosine-kinase1 (sphk1)  /  and sphingosine-kinase2  / 
mice were used. sgpl1 þ/  or sgpl1  /  pups were inbred in a Swiss Webster
genetic background. Heterozygous sgpl1 þ/  non-inbred mouse was generated
from gene trapped ES cells (OST 58278) by Lexicon Inc. (The Woodlands, TX,
USA) on a fee basis.
36 To generate the sphk1 and sphk2 null mice,a genomic DNA
fragment was cloned containing the sphk1 and sphk2 gene, respectively, from a
129/sv strain library inbred in a C57/BL6 background.
26,37 For all transgenic mice,
heterozygous matings were set up to generate homozygous mutant mice. Mice
were bred in the animal house of the University in Bonn (Germany).
The neuronal cells were cultured as described before.
14 Brieﬂy, cells were
isolated by mild trypsinization (0.05% w/v) and dissociated by repeated passage
through a constricted Pasteur pipette in a DNase solution (0.1% w/v). The cells
were then suspended in Dulbecco’s modiﬁed Eagle medium (containing 10%
heat-inactivated horse serum, penicillin 100U/l, and streptomycin 100mg/l) and
plated on to poly-L-lysine-coated 8cm
2 Petri dishes (6 10
6 cells/dish). At day 5
in culture primary neurons were treated with 10mM cimes (synthesized as
described
38), S1P, or the caspase-9 inhibitor Z-LEHD-FMK (R&D Systems,
Wiesbaden,Germany)fortheindicatedtimes.Insomeexperimentspre-incubations
with the calpain inhibitor MDL28170 (Sigma, Taufkirchen, Germany) or the cell
permeable calcium-chelator Bapta-AM (Invitrogen, Karlsruhe, Germany) were
performed as indicated.
Calcium imaging. Neurons were loaded with the Ca
2þ sensitive dye Fura-2-
AM (3mM, Molecular Probes Europe BV, Leiden, The Netherlands) at 371Ci n
bicarbonate-buffered saline solution containing (mM): 156 NaCl, 2 KCl, 2 CaCl2,
1MgCl2,26NaHCO3,1.25NaH2PO4and10 glucose,gassedwith5% CO2,pH 7.3.
Background corrected ﬂuorescence was taken with a slow-scan CCD camera
system with fast monochromator (TILL Photonics, Grafelﬁng, Germany) coupled on
an Axiovert 100 microscope equipped with an Neoﬂuar objective ( 10, Zeiss,
Oberkochen, Germany). Fura-2 was excited at 357 and 380nm wavelengths, and
ﬂuorescence was collected between 500 and 540nm at a frequency of 0.5Hz. The
change in [Ca
2þ]i is presented as the change in the ﬂuorescence ratio obtained at
the two excitation wavelengths (F357/F380). This experimental set-up allowed for
the two-dimensional representation of Ca
2þ signals in all cells simultaneously.
Average values of ﬂuorescence intensity from somatic regions were chosen for
quantiﬁcation(B50–80pixels)andanalyzedoff-linewithroutineswritteninIgorPro
software(Wavemetrics,Eugene,OR,USA).Aneuronwasincludedintheanalysisif
the peak of the response from a 30s reference application of 30mM KCl was larger
than threshold, deﬁned as six S.D. of the baseline noise.
39 The same baseline S.D.
criterion was used to count cells responsive to other substances and to calculate
the average peak amplitudes. All recordings were carried out at room temperature
(22–251C) in Hepes-buffered saline containing (mM): 145 NaCl, 2.5 KCl, 2 CaCl2,
1.3 MgCl2, 10 Hepes and 20 glucose, pH 7.3. In solutions with elevated KCl
(20mM), NaCl concentration was reduced by the same amount. Solutions were
applied using a focal perfusion system (DAD-12, ALA Scientiﬁc Instruments,
Westbury, NY, USA).
Caspase assay. Caspase assays were performed according to provider’s
protocol (Invitrogen). Cell pellets were re-suspended in 50ml of cold lysis buffer
and incubated in ice for 15min. After addition of 50ml reaction buffer, containing
dithiothreitol (10mM) and IETD-, LEHD- or DEVD-p-nitroaniline substrate (50mM),
samples were incubated for 2h at 371C in the absence of light. Absorbance was
measured at 405nm. Caspase activities are expressed relative to untreated
wild-type controls.
Cell viability assay. For quantiﬁcation of cell death in cultured cells, we
employed the CellTiter-Blue Cell Viability Assay (BD Pharmingen, Heidelberg,
Germany), which is based on the conversion of resazurin to the ﬂuorescent product
resoruﬁn exclusively by metabolically active (viable) cells. Following the indicated
treatment of neurons, 100ml of CellTiter-Blue reagent were added to each cell
culture dish. After 1h of incubation, ﬂuorescence of resoruﬁn was recorded in an
aliquot (100ml) culture medium at 544Ex/590Em.
Genomic DNA analysis. Genomic DNA analysis was performed as
described previously.
12 In brief, cells were harvested in the respective medium
and centrifuged (2000 g, 10min, 41C), thus collecting both adherent and
detached cells. Cell pellets were then re-suspended in 500ml ice cold phosphate-
buffered saline (PBS) and centrifuged again (2000 g, 10min, 41C). Genomic
DNA was puriﬁed using QIAamp DNA Blood Mini Kits (Qiagen, Hilden, Germany)
according to the protocol of the provider. Finally, samples were loaded onto a 1.6%
agarose gel. Following electrophoresis DNA was visualized under UV light using
ethidium bromide.
Mitochondrial integrity. JC-1 (Cell Technology Inc., Mountain View, CA,
USA) is a common tool to assess the polarization status of mitochondrial
membranes. This ﬂuorescent dye forms so-called J-aggregates (red ﬂuorescence)
in intact negatively charged mitochondria. As soon as the mitochondrial membrane
potential collapses, JC-1 is dispersed throughout the cell in a monomeric form
(green ﬂuorescence). Thus, neurons were pretreated as indicated and incubated
with JC-1 following provider’s protocol. Then cells were washed and JC-1
monomers were assessed using excitation/emission wavelength of 485/530nm,
while J-aggregates were measured at 560/595nm.
In addition, cytochrome c release was analyzed using the cytochrome c release
apoptosis assay kit from Calbiochem (Merck, Darmstadt, Germany) following
provider’s protocol.
Neuroanatomical studies. Mice (7 weeks of age) were killed by an
overdose of chloroform and then perfused via the left ventricle with So ¨rensen
phosphate buffer containing 1% procaine followed by a further perfusion with either
6% glutardialdehyde (for epoxy resin embedding and semi-thin sectioning) or 2%
paraformaldehyde (for further vibratome sections and immunohistochemistry)in the
same buffer. For epoxy resin embedding, tissues were post-ﬁxed at least overnight,
rinsed in buffer, and dissected tissue samples embedded in Epon/glycid ether after
osmication following standard procedures. Sections were cut at 1mm and stained
with toluidine blue/pyronin G. For immunohistochemistry, brains were rinsed in
So ¨rensen buffer, encased in agarose and cut on a high-frequency vibratome
(Leica VT 1200 S, Leica, Wetzlar, Germany). After antigen retrieval and blocking,
sections were incubated with an S1P-lyase antibody (Abcam, Cambridge, UK) at
a 1:100 dilution, and the binding of the primary antibody was detected by the use
of a HRP-tagged secondary antibody using tyramide-FITC (NEN-Dupont) as a
ﬂuorescent substrate. Nuclear counterstaining was done with bisbenzimide
(Sigma, Deisenhofen, Germany). Specimens were photographed on an Nikon 90i
epiﬂuorescence microscope equipped with a 4-channel EZ-C1 confocal laser
system.
Western blotting. SDS-PAGE and western blotting were performed as
described earlier.
12 Cells were lysed for 10min at 41C in cell lysis buffer (Cell
Signaling, Danvers, MA, USA) containing protease inhibitors (Invitrogen). Cell
extracts were centrifuged at 10000 g for 10min at room temperature to separate
insolublematerial,followedbydeterminationofproteinconcentrationusingtheBCA
assay (Sigma–Aldrich, Taufkirchen, Germany). Proteins from each sample were
mixed with loading buffer (RotiLoad, Roth, Karlsruhe, Germany), boiled for 10min
and subjected to SDS-PAGE followed by transfer to nitrocellulose membranes for
6min via the iBlot (Invitrogen). Membranes were blocked for 1h with 5% non-fat
milk in TBS at room temperature and subsequently probed with the desired primary
antibody. Blots were revealed by ECL (Amersham Biosciences, Freiburg,
Germany). The following primary antibodies were used: calpain1 (15C10), cyclin
D1 (A-12), CDK5 (J-3), p35 (C-19) for p25, a-tubulin (H-300) from Santa Cruz
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Cell Death and DifferentiationBiotechnology (Heidelberg, Germany); caspase-12, pRb (Ser 807/811), Rb (4H1)
from Cell Signaling; PHF-1 from P Davies (Albert Einstein College, Bronx, NY,
USA), 12E8 from P Seubert (Elan Pharmaceuticals, South San Francisco, CA,
USA) and K9JA from DAKO (Glostrup, Denmark); cytochrome c from cytochrome c
release apoptosis assay kit. Primary antibodies were diluted in blocking solution in
accordancewithprovider’sprotocol.Secondaryantibodieswerediluted1:40000in
TBST. To conﬁrm equal amounts of protein loaded for each sample, blots were
reprobed with respective antibody (Rb, a-tubulin). Some western blots were
densitometrically evaluated using the AlphaDigiDoc gel documentation system
(Bio-Rad, Mu ¨nchen, Germany). In each experiment the ratio of absorbance of the
respective protein versus loading control was calculated.
Presentation of data and statistics. All experiments were repeated at
least three times with consistent results in double determinations. Data are
expressedasmeanvalues±S.D.orS.E.M.andnormalizedasindicated.Statistical
analysis was performed using Student’s t-test. Statistical signiﬁcance was tested
at 95% (Po0.05) conﬁdence level. Results presented as DNA or protein gels
correspond to data obtained with at least three different cell preparations.
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